CCL Biomedical Overview
- Founded
-
2002
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
CCL Biomedical General Information
Description
Developer of antimicrobial compounds intended to be used for combatting serious health issues and reducing the number of infections and deaths. The company's antimicrobial compounds helps in effective destruction of micro-organisms and biofilm control, enabling clients to avail effective products to address their individual needs.
Contact Information
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
- Havre de Grace, MD 21078
- United States
+1 (240) 000-0000
CCL Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 01-Apr-2018 | Completed | Out of Business | |||
| 5. Later Stage VC | Completed | Generating Revenue | ||||
| 4. Grant | 01-Jan-2013 | 00000 | Completed | Generating Revenue | ||
| 3. Grant | 01-Jan-2009 | 00000 | Completed | Generating Revenue | ||
| 2. Grant | 01-Jan-2007 | $600K | Completed | Generating Revenue | ||
| 1. Grant | 01-Jan-2003 | $270K | Completed | Generating Revenue |
CCL Biomedical Patents
CCL Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2007217780-A1 | Generation of antimicrobial surfaces using dendrimer biocides | Active | 17-Feb-2006 | 0000000000 | |
| CA-2642752-A1 | Generation of antimicrobial surfaces using dendrimer biocides | Active | 17-Feb-2006 | 0000000000 | |
| AU-2007217780-B2 | Generation of antimicrobial surfaces using dendrimer biocides | Inactive | 17-Feb-2006 | 0000000000 | |
| CA-2642752-C | Generation of antimicrobial surfaces using dendrimer biocides | Inactive | 17-Feb-2006 | 0000000000 | |
| EP-1988770-A4 | Generation of antimicrobial surfaces using dendrimer biocides | Inactive | 17-Feb-2006 | C08G83/005 | 0 |
CCL Biomedical Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Stuart Cooper | Co-Founder |
CCL Biomedical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
